Annual Total Debt
$117.19 M
+$67.30 M+134.90%
December 31, 2023
Summary
- As of February 7, 2025, MDGL annual total debt is $117.19 million, with the most recent change of +$67.30 million (+134.90%) on December 31, 2023.
- During the last 3 years, MDGL annual total debt has risen by +$116.41 million (+14810.05%).
- MDGL annual total debt is now at all-time high.
Performance
MDGL Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$119.14 M
+$1.08 M+0.91%
September 30, 2024
Summary
- As of February 7, 2025, MDGL quarterly total debt is $119.14 million, with the most recent change of +$1.08 million (+0.91%) on September 30, 2024.
- Over the past year, MDGL quarterly total debt has increased by +$1.08 million (+0.91%).
- MDGL quarterly total debt is now at all-time high.
Performance
MDGL Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
MDGL Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +134.9% | +0.9% |
3 y3 years | +10000.0% | +0.9% |
5 y5 years | +100.0% | +0.9% |
MDGL Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% |
5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
alltime | all time | at high | -100.0% | at high | -100.0% |
Madrigal Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $119.14 M(+0.9%) |
Jun 2024 | - | $118.06 M(+0.3%) |
Mar 2024 | - | $117.72 M(+0.5%) |
Dec 2023 | $117.19 M(+134.9%) | $117.19 M(+0.5%) |
Sep 2023 | - | $116.56 M(+17.0%) |
Jun 2023 | - | $99.66 M(+17.8%) |
Mar 2023 | - | $84.62 M(+69.6%) |
Dec 2022 | $49.89 M(+6159.8%) | $49.89 M(+0.2%) |
Sep 2022 | - | $49.81 M(+0.2%) |
Jun 2022 | - | $49.73 M(+7044.7%) |
Mar 2022 | - | $696.00 K(-12.7%) |
Dec 2021 | $797.00 K(+1.4%) | $797.00 K(-11.1%) |
Sep 2021 | - | $897.00 K(-10.0%) |
Jun 2021 | - | $997.00 K(+41.0%) |
Mar 2021 | - | $707.00 K(-10.1%) |
Dec 2020 | $786.00 K(+16.3%) | $786.00 K(-8.9%) |
Sep 2020 | - | $863.00 K(+66.0%) |
Jun 2020 | - | $520.00 K(-13.0%) |
Mar 2020 | - | $598.00 K(-11.5%) |
Dec 2019 | $676.00 K(>+9900.0%) | $676.00 K(-10.0%) |
Sep 2019 | - | $751.00 K(-9.1%) |
Jun 2019 | - | $826.00 K(-8.2%) |
Mar 2019 | - | $900.00 K(>+9900.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(0.0%) |
Jun 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(-100.0%) |
Jun 2016 | - | $32.00 K(-98.6%) |
Mar 2016 | - | $2.33 M(-95.2%) |
Dec 2015 | $48.60 M(+249.5%) | $48.60 M(+597.5%) |
Sep 2015 | - | $6.97 M(-24.9%) |
Jun 2015 | - | $9.28 M(-19.9%) |
Mar 2015 | - | $11.60 M(-16.6%) |
Dec 2014 | $13.91 M | $13.91 M(-14.2%) |
Sep 2014 | - | $16.22 M(-12.5%) |
Jun 2014 | - | $18.52 M(-11.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2014 | - | $20.90 M(-10.7%) |
Dec 2013 | $23.40 M(+88.7%) | $23.40 M(-0.5%) |
Sep 2013 | - | $23.51 M(-0.9%) |
Jun 2013 | - | $23.73 M(+0.4%) |
Mar 2013 | - | $23.64 M(+90.6%) |
Dec 2012 | $12.40 M(-25.5%) | $12.40 M(-13.7%) |
Sep 2012 | - | $14.37 M(-12.0%) |
Jun 2012 | - | $16.34 M(-1.0%) |
Mar 2012 | - | $16.49 M(-0.9%) |
Dec 2011 | $16.65 M(+40.0%) | $16.65 M(-0.9%) |
Sep 2011 | - | $16.80 M(-0.9%) |
Jun 2011 | - | $16.96 M(-1.1%) |
Mar 2011 | - | $17.14 M(+44.1%) |
Dec 2010 | $11.89 M(+477.1%) | $11.89 M(-12.8%) |
Sep 2010 | - | $13.65 M(+876.9%) |
Jun 2010 | - | $1.40 M(-18.4%) |
Mar 2010 | - | $1.71 M(-16.9%) |
Dec 2009 | $2.06 M(-50.7%) | $2.06 M(-15.7%) |
Sep 2009 | - | $2.44 M(-18.5%) |
Jun 2009 | - | $3.00 M(-75.3%) |
Mar 2009 | - | $12.13 M(+190.2%) |
Dec 2008 | $4.18 M(-19.9%) | $4.18 M(-11.2%) |
Sep 2008 | - | $4.71 M(-13.0%) |
Jun 2008 | - | $5.42 M(+9.1%) |
Mar 2008 | - | $4.96 M(-4.9%) |
Dec 2007 | $5.22 M(-5.1%) | $5.22 M(-6.6%) |
Sep 2007 | - | $5.59 M(-2.1%) |
Jun 2007 | - | $5.71 M(-1.9%) |
Mar 2007 | - | $5.82 M(+5.7%) |
Dec 2006 | $5.50 M(-10.9%) | $5.50 M(-3.4%) |
Sep 2006 | - | $5.69 M(>+9900.0%) |
Jun 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(-100.0%) |
Dec 2005 | $6.17 M(+257.9%) | $6.17 M(>+9900.0%) |
Sep 2005 | - | $0.00(0.0%) |
Jun 2005 | - | $0.00(-100.0%) |
Mar 2005 | - | $2.32 M(>+9900.0%) |
Dec 2004 | $1.73 M(>+9900.0%) | - |
Mar 2004 | - | $0.00 |
Dec 2003 | $0.00(0.0%) | - |
Dec 2002 | $0.00(0.0%) | - |
Dec 2001 | $0.00 | - |
FAQ
- What is Madrigal Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual total debt year-on-year change?
- What is Madrigal Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly total debt year-on-year change?
What is Madrigal Pharmaceuticals annual total debt?
The current annual total debt of MDGL is $117.19 M
What is the all time high annual total debt for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual total debt is $117.19 M
What is Madrigal Pharmaceuticals annual total debt year-on-year change?
Over the past year, MDGL annual total debt has changed by +$67.30 M (+134.90%)
What is Madrigal Pharmaceuticals quarterly total debt?
The current quarterly total debt of MDGL is $119.14 M
What is the all time high quarterly total debt for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly total debt is $119.14 M
What is Madrigal Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, MDGL quarterly total debt has changed by +$1.08 M (+0.91%)